60 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
6919
NT$109.505.3%-43.7%NT$159.4bNT$240.005794.4136.5%n/aPharmaceuticals & Biotech
6472
NT$443.505.1%-40.9%NT$51.6bNT$571.9031.045.2%2.3%Pharmaceuticals & Biotech
4728
New
NT$395.502.1%-3.1%NT$21.5bn/a29.8n/a3.1%Pharmaceuticals & Biotech
4105
NT$79.202.7%4.2%NT$19.1bNT$92.0011.4n/a5.7%Pharmaceuticals & Biotech
1789
NT$19.503.4%7.7%NT$15.0bn/a408.7n/a1.5%Pharmaceuticals & Biotech
3705
NT$55.702.4%-0.4%NT$14.6bn/a16.6n/a5.4%Pharmaceuticals & Biotech
6620
NT$76.10-5.8%-7.2%NT$12.5bNT$100.0025.936.8%2.6%Pharmaceuticals & Biotech
1720
NT$56.900.9%11.2%NT$11.0bn/a10.9n/a3.2%Pharmaceuticals & Biotech
4169
NT$163.509.0%92.8%NT$8.8bNT$194.0013.8135.1%0.2%Pharmaceuticals & Biotech
6550
NT$11.150.5%-72.7%NT$8.7bn/a138.4n/an/aPharmaceuticals & Biotech
4162
NT$59.50-6.4%-12.5%NT$8.4bn/a15.9n/a3.4%Pharmaceuticals & Biotech
4142
NT$18.104.6%3.1%NT$7.3bn/a5.6n/a0%Pharmaceuticals & Biotech
6976
NT$11.850.4%-25.7%NT$7.0bn/a1.4n/an/aPharmaceuticals & Biotech
4167
NT$20.7012.8%17.9%NT$6.6bn/a6.7n/a3.6%Pharmaceuticals & Biotech
4746
NT$53.900.9%-17.3%NT$6.3bn/a13.6n/a5.6%Pharmaceuticals & Biotech
1734
NT$32.451.9%6.1%NT$6.1bn/a17.6n/a3.1%Pharmaceuticals & Biotech
4166
NT$24.05-1.8%-14.0%NT$5.4bn/a22.8n/an/aPharmaceuticals & Biotech
3716
NT$35.901.8%5.9%NT$5.1bn/a13.9n/a2.8%Pharmaceuticals & Biotech
4726
NT$24.751.6%-34.5%NT$5.0bn/a6.3n/an/aPharmaceuticals & Biotech
3176
NT$35.554.1%17.5%NT$4.7bn/a3.9n/an/aPharmaceuticals & Biotech
6875
NT$32.701.4%-34.3%NT$4.2bn/a79.1n/an/aPharmaceuticals & Biotech
4120
NT$47.00-4.1%-11.0%NT$4.1bn/a0.9n/a8.5%Pharmaceuticals & Biotech
7876
NT$36.40-2.8%n/aNT$3.9bn/a2.8n/an/aPharmaceuticals & Biotech
1799
NT$30.05-0.5%-32.9%NT$3.7bn/a4.7n/an/aPharmaceuticals & Biotech
Page 1 of 2